Cue Biopharma Inc (CUE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Sales | 1,000 | 8,254 | 2,395 | 2,739 | 1,553 |
| Gross Profit | 1,000 | 8,254 | 2,395 | 2,739 | 1,553 |
| Operating Expenses | 15,238 | 16,127 | 15,413 | 13,042 | 14,071 |
| Operating Income | -14,238 | -7,873 | -13,018 | -10,303 | -12,518 |
| Interest Expense | 25 | 0 | 0 | 0 | 0 |
| Other Income | 8 | -16 | 25 | 24 | 13 |
| Pre-tax Income | -14,255 | -7,889 | -12,993 | -10,279 | -12,505 |
| Net Income Continuous | -14,255 | -8,384 | -12,993 | -10,279 | -12,505 |
| Net Income | $-14,255 | $-8,384 | $-12,993 | $-10,279 | $-12,505 |
| EPS Basic Total Ops | -0.44 | -0.26 | -0.41 | -0.33 | -0.41 |
| EPS Basic Continuous Ops | -0.44 | -0.26 | -0.41 | -0.33 | -0.41 |
| EPS Diluted Total Ops | -0.44 | -0.26 | -0.41 | -0.33 | -0.41 |
| EPS Diluted Continuous Ops | -0.44 | -0.26 | -0.41 | -0.33 | -0.41 |
| EBITDA(a) | $-13,932 | $-7,563 | $-12,702 | $-9,989 | $-12,205 |